Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Profit After Tax: 2010-2025

Historic Profit After Tax for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to $779000.0.

  • OptimizeRx's Profit After Tax rose 10853.79% to $779000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $34000.0, marking a year-over-year increase of 10014.07%. This contributed to the annual value of -$20.1 million for FY2024, which is 1448.25% down from last year.
  • Latest data reveals that OptimizeRx reported Profit After Tax of $779000.0 as of Q3 2025, which was up 10853.79% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Profit After Tax ranged from a high of $1.5 million in Q2 2025 and a low of -$9.1 million during Q3 2024
  • Over the past 5 years, OptimizeRx's median Profit After Tax value was -$2.9 million (recorded in 2023), while the average stood at -$2.6 million.
  • In the last 5 years, OptimizeRx's Profit After Tax crashed by 879000.85% in 2022 and then surged by 13822.36% in 2025.
  • Quarter analysis of 5 years shows OptimizeRx's Profit After Tax stood at $623462.0 in 2021, then tumbled by 152.26% to -$325836.0 in 2022, then tumbled by 1171.19% to -$4.1 million in 2023, then soared by 98.12% to -$78000.0 in 2024, then skyrocketed by 1098.72% to $779000.0 in 2025.
  • Its last three reported values are $779000.0 in Q3 2025, $1.5 million for Q2 2025, and -$2.2 million during Q1 2025.